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Resonance Raman Probes of the Internal Binding Pocket of Dehaloperox-
idase from Amphitrite ornata
Matthew K. Thompson, Michael F. Davis, Stefan Franzen.
North Carolina State University, Raleigh, NC, USA.
Using Resonance Raman spectroscopy and activity assays we have determined
that there are potent inhibitors of DHP activity and these inhibitors play a major
role in the biology of DHP. Resonance Raman spectroscopy can detect sub-
strate or inhibitor binding by monitoring shifts in the core size marker modes,
n2 and n3, and the vinyl substituent mode, nC¼C, of the heme. Para-halogenated
phenols bind internally, displacing the sixth position water molecule of the iron
(in agreement with X-ray crystallography) resulting in a 5-coordinate high spin
heme. Tri-halogenated phenols bind externally, forcing the distal histidine into
the closed conformation (also in agreement with X-ray crystallography) result-
ing in a 6-coordinate high spin heme. The internal and external binding sites are
supported by NMR data. X-ray crystallography shows when para-halogenated
phenols bind internally, the halogen plugs into a hydrophobic cavity just above
the back edge of the distal pocket that is analogous to the xenon 4 binding site in
Sperm whale met-myoglobin often referred to as a ‘‘packing defect.’’ Analysis
of the X-ray crystal structures of the 4-iodo-, 4-bromo-, and 4-chlorophenol/
DHP complexes show a general trend in the position of the halogenated phenol
with 4-iodophenol binding farthest into the cavity followed by 4-bromophenol,
and 4-chlorophenol. Using RR spectroscopy, we demonstrate that the dissoci-
ation constants of the para-halogenated phenols mimic the trend observed in X-
ray crystallography with 4-iodophenol being the most tightly bound in the distal
pocket. DHP clearly demonstrates the importance of the hydrophobic cavity as
an inherent selector for substrates entering the distal pocket by making use of
the cavity-halogen hydrophobic interaction concomitantly preventing non-ha-
logenated substrates from binding. Using activity assays, we demonstrate
that internal binding of mono-halogenated phenols inhibits the function of
DHP on the externally bound tri-halogenated substrates.
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Spectroscopic Probes of the Reactive Intermediates of Dehaloperoxidase
from Amphitrite ornata
Reza A. Ghiladi, Rania Dumarieh, Matthew Thompson, Zao Wang,
Tatyana Smirnova, Stefan Franzen.
North Carolina State University, Raleigh, NC, USA.
The enzyme intermediates of dehaloperoxidase (DHP) from the marine worm
Amphitrite ornata are unique within both the globin and cytochrome c peroxi-
dase superfamilies. DHP has been shown to oxidize trihalophenols to dihaloqui-
nones in a dehalogenation reaction that uses hydrogen peroxide as a substrate.
We show that the initially formed heme intermediate in this reaction is not Com-
pound I as is often the case in peroxidases, but rather is a combination of Com-
pound II and a tyrosyl radical that has similarity to the Compound ES intermedi-
ate of cytochrome c peroxidase. Using stopped-flow UV-visible spectroscopy,
we provide a detailed kinetic description for the reaction of pre-formed DHP
Compound II and tyrosyl radical with the substrate 2,4,6-trichlorophenol, and
demonstrate the catalytic competency of this intermediate in generating the prod-
uct 2,4-dichloroquinone. Furthermore, using rapid-freeze-quench electron para-
magnetic resonance spectroscopy, we detected a signal at gz 2.0058, confirm-
ing the presence of a protein radical in DHP Compound II, and assign it as
a tyrosyl radical based upon mutagenesis studies and structural arguments. In
the absence of a halophenol substrate, the DHP Compound II þ tyrosyl radical
intermediate decomposes to a new and significantly less active species, termed
Compound RH, which is unique to dehaloperoxidase. We propose that this inter-
mediate plays a protective role against heme bleaching. While unreactive toward
further oxidation, Compound RH can be reduced and subsequently bind dioxy-
gen, generating oxyferrous DHP, which may represent the catalytic link between
the peroxidase and oxygen-transport activities in this bifunctional protein.
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Substrate binding triggers a switch in the iron coordination in dehaloper-
oxidase from Amphitrite Ornate
Tatyana I. Smirnova1, Mike F. Davis1, Ralph T. Weber2, Stefan Franzen1.
1North Carolina State University, Raleigh, NC, USA, 2BioSpin Corporation,
EPR Division, Billerica, MA, USA.
We have explored the effect of substrate binding on the heme iron conforma-
tion in the enzyme dehaloperoxidase (DHP). DHP is a dimeric hemoglobin
that also has significant peroxidase activity under physiological conditions
and has been shown to oxidize trihalophenols to dihaloquinones in a dehaloge-
nation reaction that uses hydrogen peroxide as a cosubstrate. Hyperfine sub-
level correlation spectroscopic (HYSCORE) analysis of the ferric form of
DHP was carried out to characterize effects of the substrate 2,4,6-trifluorophe-
nol (TFP) binding on the iron coordination in order to elucidate molecularmechanisms responsible for switching the protein function from a globin to
a peroxidase. The CW EPR spectrum shows that at pH 6.0 DHP heme iron ex-
ists in a highly axial high spin (HS) state that could be interpreted as arising
from two different populations of the HS iron centers. Substrate binding does
not change the spin state at pH 6.0, however, affects the magnetic parameters
of the signal. HYSCORE spectra recorded at magnetic field corresponding to
g ¼ 2 revealed the presence of exchangeable protons with hyperfine coupling
of ca. 6 MHz, consistent with a water molecule being the sixth ligand in the iron
coordination. These protons’ spectral features disappeared upon substrate bind-
ing. At pH 9.6 the EPR spectrum from heme iron of DHP shows the presence of
both high- and low-spin states with the low spin signal characteristic of hy-
droxyl form. Upon TFP binding the low spin signal disappears. HYSCORE
spectra at pH 9.6 also show the presence of exchangeable protons that disappear
upon substrate binding. This observation highlights the proposed role of mole-
cules in the distal pocket to control the peroxidase function of DHP.
Supported by the NSF Grant MCB-0451510 to T.I.S. and ARO grant 52278-LS
to S.F.
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Dynamics And Energetics Associated With Ligand Photodissociation
From Co Bound Chloroperoxidase
Simona Horsa, Lin Jiang, Xiaotang Wang, Jaroslava Miksovska.
Florida International University, Miami, FL, USA.
Chloroperoxidase (CPO) is the most versatile heme peroxidase that can func-
tion as peroxidase, catalase, halogenase/dehalogenase and monooxigenase.
The active site of CPO strongly resembles that of cytochrome P450 since the
heme iron in both proteins is coordinated with a Cys axial ligand. Two hydro-
phobic channels that connect the heme binding cavity with the surrounding are
likely to provide ligand access into the active site. At alkaline pH the protein
undergoes a conformational transition resulting in the population of six coordi-
nated heme iron with the histidine residue in the position of the sixth ligand.
Here we report the results of the photoacoustic study of ligand dissociation
from CPO. The ligand photodissociation and migration out of the protein ma-
trix occurs within 50 ns and no additional kinetics was determined (detected?)
between 50 ns and 5 ms. At acidic pH ligand dissociation is associated with
a positive volume change (FDV¼ 10.95 0.9 mL mol1) and enthalpy change
(FDH ¼ 245 5 kcal mol1), strongly indicating that the ligand release from
the protein matrix does not result in significant changes in protein conformation
and CO is likely to migrate through one of the hydrophobic channels. On the
other hand, the thermodynamic parameters associated with CO photorelease
at pH 10 are significantly smaller than those determined at acidic pH (FDV
¼ 3.25 1.1 mL mol1 and FDH ¼ -12.15 5.3 kcal mol1) due to changes
in heme coordination upon CO dissociation.
2255-Pos Board B225
Hierarchical Structures of Natural Acellular Polymeric Hemoglobins:
Model for Design of a Therapeutic Hemoglobin-Based-Oxygen-Carrier
(HBOC)
John P. Harrington1, Kseniya Orlik1, Hanna Wollocko2.
1SUNY New Paltz, New Paltz, NY, USA, 2OxyVita, Inc, New Windsor, NY,
USA.
Natural acellular polymeric hemoglobins provide oxygen transport/delivery
within many terrestrial and marine invertebrate organisms. It has been our prem-
ise that these natural acellular Hbs can serve as models for development of ther-
apeutic hemoglobin-based oxygen carriers (HBOC). Understanding of how
organisms utilize acellular oxygen carriers and maintain their structural integrity
and redox stability within their circulatory systems is vital for the design of a safe
and effective red cell substitute. Biophysical characterizations of naturally avail-
able acellular Hbs are warranted to determine unique structural and chemical
properties that contribute to their success as acellular oxygen carriers. Our atten-
tion has focused on acellular Hbs from a terrestrial (Lumbricus terrestris) and
marine (Arenicola marina) invertebrate, testing the hypothesis that their unique
hierarchical structure and functional properties are significant in their success as
a natural oxygen carrier. Structural and redox properties of these polymeric in-
vertebrate Hbs were studied. Structural stability was evaluated by: 1) alkaline
pH dissociation of the intact duodecamer (in vivo molecular hierarchy) by gel
chromatography (pH 7.0-9.1 range), and 2) isothermal urea unfolding studies.
Redox properties were examined by a comparison of the rates of autoxidation
(heme-Feþ2/heme-Feþ3) of each of these invertebrate Hbs and compared to
a unique zero-linked high M. wt. polymeric hemoglobin (OxyVitaTM) devel-
oped for application at the veterinary and clinical levels. This ‘‘super polymer’’
has an average M.wt.¼17  106 Da and a viscosity at 6g% comparable to
plasma. Initial pre-clinical studies using the liquid or powder form of OxyVitaTM
clearly demonstrate no increase in mean arterial pressure (MAP) upon injection,
indicating that its molecular size prevents vascular extravasation.
